tickstock newsroom AI
Articles
Health & Bio Today: Thalia Therapeutics acquires AML RNA therapy firm in £2.75m-backed deal, Primary Health Properties, Verici Dx, Beximco Pharmaceuticals, Cambridge Cognition
An oncology acquisition anchored the health and biotech session, as Thalia Therapeutics (AIM:THAT) moved to add a clinical-stage RNA therapy to its pipeline through an oversubscribed fundraise. Away from the deal, Primary Health Properties advanced joint venture talks, Verici Dx completed its US reg
Mining Today: Anglo American and Codelco seal Los Bronces-Andina copper deal, Cobra Resources, Kodal Minerals, Essentra, Kenmare Resources
A landmark copper joint operations agreement between Anglo American and Codelco dominated mining news, while rare earth drilling results from Cobra Resources defined a substantial high-grade zone in South Australia. Elsewhere, a broker maintained its conviction on Kodal Minerals' lithium ramp-up, Es
Micron earnings set to test AI chip demand as oil dip steadies markets
Investors are watching Micron's results as a read on AI capital spending sustainability, with crowded semiconductor positioning amplifying the stakes after a tech-driven selloff.
Deutsche Bank raises Bunzl target to 2,950p on North America progress and volume recovery
The broker lifts its price target and reiterates its 'buy' rating after Bunzl's first-half trading update signals broadening momentum beyond temporary pricing tailwinds.
Deutsche Bank lifts St James's Place target to 2,050p with 79% upside in sight
Shares in the wealth manager has further to run
Panmure Liberum raises Foresight Environmental Infrastructure target to 92p after 33% share run
The broker lifts its price target by 19p and sees a further 18% total shareholder return ahead as growth investments and improved disclosure shift investor perception.
Deutsche Bank lifts Diageo price target to 1759p on rising US promotional activity
Analyst Mitch Collett flags accelerating promotional spend in US Nielsen data as a potential stabilising signal for Diageo's troubled North American business.
Interactive Investor sees Berkeley Group caught at the bottom of the cycle but eyes long-term recovery
Analyst Richard Hunter says the London housebuilder is navigating a difficult regulatory and economic environment but retains confidence in its structural housing thesis.
Panmure Liberum reiterates 'buy' on Trainline after Ian Brown CEO appointment
The broker sees the hiring of a former Booking.com and Flutter executive as a strong fit for the rail-retailing platform.
SP Angel trims Kodal Minerals target but maintains 'buy' on Bougouni ramp-up
The broker sees stronger spodumene pricing and rising shipment volumes as the key re-rating catalysts for the AIM-listed lithium miner.
SpaceX sheds $600bn from IPO peak as tech sell-off rattles Nasdaq and Kospi
A 30% reversal in SpaceX from its post-IPO high has become the focal point of a broader technology sector pullback, with the Nasdaq 100 down a further 2.5% and South Korea's Kospi off 10%.
Small Caps Today: Thalia Therapeutics acquires AML RNA therapy firm in £2.75m-backed deal, Vertu Motors, CyanConnode, Pennant International, Seed Innovations
A busy session for small-cap corporate activity was headlined by Thalia Therapeutics' transformative acquisition of an RNA oncology company, backed by an oversubscribed fundraise, while Vertu Motors lifted full-year profit guidance on broad trading strength and a M&A deadline loomed over CyanConnode
Segro shares jump as Prologis goes public with £12.6 billion takeover approach
US logistics giant urges shareholders to press Segro's board into talks after an all-share proposal was rejected.
London LIVE — 2026-06-24
Live market updates for 2026-06-24
Market Brief: Thalia Therapeutics acquires AML RNA therapy firm in £2.75m-backed deal, Ratio Petroleum bids for Pharos Energy, Vertu Motors, Anglo American
A busy morning of corporate news spans oncology M&A, a recommended takeover bid in oil and gas, and operational updates from automotive retail to copper mining. Thalia Therapeutics (AIM:THAT)'s acquisition of Sanmirna Therapeutics leads the agenda, while an all-cash approach for Pharos Energy (AIM:P
Pennant International lands first Auxilium-GenS sale through Siemens distribution deal
The AIM-listed systems support software group has completed its first commercial sale of Auxilium-GenS via Siemens Digital Industries Software, less than three months after the two companies agreed a global distribution partnership.
Thor Energy awards 2D seismic contract at South Australia hydrogen project
Thor Energy has signed a Letter of Award for a 464-kilometre 2D seismic survey at its HY-Range project in South Australia, a key step toward identifying drill targets for natural hydrogen and helium.
Georgina Energy secures land rights agreement unlocking Mt Winter helium and hydrogen permit
Ratio Petroleum makes all-cash recommended bid for Pharos Energy
Israel-based exploration group Ratio Petroleum Energy has launched a recommended all-cash acquisition of London-listed Pharos Energy, structured as a scheme of arrangement, citing the combined group's ability to fund exploration growth that Pharos cannot pursue at its current scale.
Cobra Resources rare earth assays define high-grade 5km zone at Head Prospect
New drilling results at Cobra Resources' South Australian project outline a scalable rare earth system with acid-generating characteristics that could cut extraction costs.